Drs S van der Geer

Drs. S. van der Geer is a clinical research and medical practice entity led by Sandra van der Geer, a Dutch dermatologist specializing in dermato-oncology and Mohs micrographic surgery. The entity is primarily focused on the clinical evaluation of therapeutic interventions for skin cancers, notably basal cell carcinoma (BCC). It has served as the primary sponsor for investigator-initiated clinical trials, including studies evaluating the efficacy of imiquimod as a neoadjuvant treatment before Mohs surgery. Based in the Netherlands, the practice is affiliated with major medical institutions such as Catharina Hospital Eindhoven and Erasmus University Medical Center. Its research contributions also include the investigation of botulinum toxin for the treatment of Hailey-Hailey disease.